MVP: King & Spalding's Andrew Bayman
King & Spalding LLP's Andrew Bayman helped limit GlaxoSmithKline's damages to $3 million in a closely watched federal trial over the company's liability for the suicide of a Reed Smith LLP...To view the full article, register now.
Already a subscriber? Click here to view full article